List view / Grid view
14 March 2014 | By GlaxoSmithKline
GlaxoSmithKline plc and Theravance, Inc. announced that recruitment of patients into the “Study to Understand Mortality and MorbidITy”, known as SUMMIT, has completed enrolment...
14 March 2014 | By Boehringer Ingelheim
More than 73 percent of physicians surveyed said the complexity of Type 2 Diabetes is underestimated...
13 March 2014 | By Roche
Roche announced that the U.S. Food and Drug Administration Microbiology Devices Panel of the Medical Devices Advisory Committee recommended unanimously that the benefits of the cobas HPV Test...
13 March 2014 | By Novartis
Novartis has announced that Australia has joined the growing number of countries where following licensure, Bexsero® has received a clinical recommendation...
12 March 2014 | By Pfizer
Study findings, presented at ISPPD, demonstrate that prevenar 13 can prevent vaccine-type community-acquired pneumonia...
12 March 2014 | By Pfizer
Pfizer Inc. confirmed that the United States District Court for the Eastern District of Virginia granted summary judgment invalidating the reissue patent, covering methods of treating osteoarthritis and other approved conditions with celecoxib...
12 March 2014 | By GlaxoSmithKline
GlaxoSmithKline plc announced that a pivotal phase III study of mepolizumab, an investigational IL-5 antagonist monoclonal antibody, met its primary endpoint of reduction in the frequency of exacerbations...
12 March 2014 | By Amgen
Amgen announced the appointment of David Piacquad to the new position of senior vice president, Business Development...
11 March 2014 | By Sanofi
Sanofi and UCB announce they have entered into a scientific and strategic collaboration for the discovery and development of innovative anti-inflammatory small molecules...
11 March 2014 | By Boehringer Ingelheim
Boehringer Ingelheim announces the enrolment of the 10,000th patient with atrial fibrillation (AF) into GLORIA™-AF, one of the largest AF registry programmes currently running worldwide...
11 March 2014 | By Amgen
Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma...
10 March 2014 | By GlaxoSmithKline
GlaxoSmithKline plc announced that GSK has successfully increased its stake in its publicly-listed pharmaceuticals subsidiary in India (GlaxoSmithKline Pharmaceuticals Limited), from 50.7% to 75%...
10 March 2014 | By Merck
Move reinforces business strategy to reach a minimum of 3% total share per key market and at least 3 leading brands in investment markets...
10 March 2014 | By Waters
2014 Honor marks fourth time in last ten years Waters' has been recognized by Pittcon Media Corps...
10 March 2014 | By Rigaku
Rigaku Raman Technologies announced its next generation handheld analyzer, the Rigaku Progenyä, designed from the ground up to deliver the industry’s most comprehensive and accurate materials identification, and improved ease of use, adaptability and reliability...
